Showing results (541-550 of 684) with videos related to
Sort By:
Pageof 69
Plos One|March 10, 2017
Zinc reduces epithelial barrier compromise induced by human seminal plasmaJames M Mullin, Katherine M Diguilio, Mary C Valenzano, et al.The Journal of Clinical Endocrinology and Metabolism|December 9, 2004
Prevalence of HLA-DRB1 genotype and altered Fas/Fas ligand expression in adrenocortical carcinomaGernot W Wolkersdörfer, Christian Marx, John Brown, et al.Glycobiology|May 25, 1999
Differential sialylation of cell surface glycoconjugates in a human B lymphoma cell line regulates susceptibility for CD95 (APO-1/Fas)-mediated apoptosis and for infection by a lymphotropic virusO T Keppler, M E Peter, S Hinderlich, et al.Endocrinology|August 23, 2003
Endogenous hypothalamic somatostatins differentially regulate growth hormone secretion from goldfish pituitary somatotropes in vitroWarren K Yunker, Sean Smith, Chad Graves, et al.Journal of the American Chemical Society|April 15, 2004
[CpRu((R)-Binop-F)(H2O)][SbF6], a new fluxional chiral Lewis acid catalyst: synthesis, dynamic nmr, asymmetric catalysis, and theoretical studiesValérie Alezra, Gérald Bernardinelli, Clémence Corminboeuf, et al.Nature Communications|November 5, 2014
CD95 and CD95L promote and protect cancer stem cellsPaolo Ceppi, Abbas Hadji, Frederick J Kohlhapp, et al.Journal of Bacteriology|August 16, 2017
Gene Duplication in Pseudomonas aeruginosa Improves Growth on AdenosineJean-Paul Toussaint, Anna Farrell-Sherman, Tamar Perla Feldman, et al.Cell and Tissue Research|January 1, 1986
A reinvestigation of the Gn-RH (gonadotrophin-releasing hormone) systems in the goldfish brain using antibodies to salmon Gn-RHO Kah, B Breton, J G Dulka, et al.Bone|October 5, 2023
Denosumab treatment lapses, discontinuation, and off-treatment fracture risk: A retrospective study of patients with osteoporosis in a real-world clinical settingKatie R Cruchelow, Megan E Peter, Anwesa Chakrabarti, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 10, 2011
Foretinib (GSK1363089), an orally available multikinase inhibitor of c-Met and VEGFR-2, blocks proliferation, induces anoikis, and impairs ovarian cancer metastasisMarion Zillhardt, Sun-Mi Park, Iris L Romero, et al.Pageof 69